Back to MORGAN STANLEY MORGAN STANLEY

KRYSKRYS
9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in Krystal Biotech, Inc.

MORGAN STANLEY holds 235,491 shares of KRYS (Krystal Biotech, Inc.), worth $87.5M as of 2026-Q2. The position was increased (+12.6% shares). KRYS represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$87.5M

Current Shares

235,491

Total Value Change

+$29.1M

Total Shares Change

-82,836

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
235,491
+12.6%
$87.5M0.0%$371.67
34
2026-Q1
Decreased
209,082
-5.6%
$54M0.0%$263.80
0
2025-Q4
Decreased
221,481
-5.6%
$54.6M0.0%$247.88
0
2025-Q3
Increased
234,578
+0.1%
$41.4M0.0%$176.75
29
2025-Q2
Decreased
234,421
-21.4%
$32.2M0.0%$138.88
0
2025-Q1
Increased
298,205
+16.4%
$53.8M0.0%$183.92
34
2024-Q4
Decreased
256,275
-7.1%
$40.1M0.0%$159.80
0
2024-Q3
Decreased
275,804
-13.4%
$50.2M0.0%$177.14
0
2024-Q2
New
318,327
-
$58.5M0.0%$183.64
41

Other major holders of KRYS: FMR LLC, BlackRock, Inc., Avoro Capital Advisors LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used